Advertisement
Advertisement
PAHC
Phibro Animal Health Corporation Class A
56.98
USDSponsored
-0.03
-0.06%
Mar 26, 10:07 UTC -4
Open
PAHC Earnings Reports
Positive Surprise Ratio
PAHC beat 25 of 40 last estimates.
63%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$372.51M
/$0.72
Implied change from Q2 26 (Revenue/ EPS)
-0.37%
/-17.24%
Implied change from Q3 25 (Revenue/ EPS)
+7.10%
/+14.29%
Phibro Animal Health Corporation Class A earnings per share and revenue
On Feb 04, 2026, PAHC reported earnings of 0.87 USD per share (EPS) for Q2 26, beating the estimate of 0.68 USD, resulting in a 27.30% surprise. Revenue reached 373.90 million, compared to an expected 362.75 million, with a 3.07% difference. The market reacted with a +21.95% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 0.72 USD, with revenue projected to reach 372.51 million USD, implying an decrease of -17.24% EPS, and decrease of -0.37% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Phibro Animal Health Corporation Class A's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Phibro Animal Health Corporation Class A reported EPS of $0.87, beating estimates by 27.3%, and revenue of $373.90M, 3.07% above expectations.
How did the market react to Phibro Animal Health Corporation Class A's Q2 2026 earnings?
The stock price moved up 21.95%, changed from $41.00 before the earnings release to $50.00 the day after.
When is Phibro Animal Health Corporation Class A expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Phibro Animal Health Corporation Class A's next earnings report?
Based on 6
analysts, Phibro Animal Health Corporation Class A is expected to report EPS of $0.72 and revenue of $372.51M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement